3-Galloylquinic acidCAS# 17365-11-6 |
- 5-Galloylquinic acid
Catalog No.:BCN3060
CAS No.:53584-43-3
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 17365-11-6 | SDF | Download SDF |
| PubChem ID | 442988 | Appearance | White-beige powder |
| Formula | C14H16O10 | M.Wt | 344.3 |
| Type of Compound | Phenols | Storage | Desiccate at -20°C |
| Synonyms | 3-Galloylquinic acid; Quinic acid 3-gallate | ||
| Solubility | Soluble in water | ||
| Chemical Name | (1S,3R,4R,5R)-1,3,4-trihydroxy-5-(3,4,5-trihydroxybenzoyl)oxycyclohexane-1-carboxylic acid | ||
| SMILES | C1C(C(C(CC1(C(=O)O)O)OC(=O)C2=CC(=C(C(=C2)O)O)O)O)O | ||
| Standard InChIKey | LDPLFHGGZNSKDS-FTBFGRRBSA-N | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | 1. L-theanine- and theogallin(3-Galloylquinic acid )-enriched decaffeinated green tea extract are able to change the physiological pattern of electrical hippocampus activity in a concentration dependent manner (EC50=3mg/L), they can improve cognition at concomitant mental relaxation in man. 2. Theogallin, its derivatives, its metabolite quinic acid, the derivatives thereof, its metabolites or the pharmaceutically acceptable salts of said substances can be used for producing a drug for use in the prophylaxis or treatment of neurological and psychiatric diseases of the central nervous system, especially of dementia such as Alzheimer's disease or Parkinson's disease, of depressions and concentration disorders such as attention deficit hyperactivity disorder. 3. Theogallin has scavenging radical activity. |
3-Galloylquinic acid Dilution Calculator
3-Galloylquinic acid Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 2.9044 mL | 14.5222 mL | 29.0444 mL | 58.0889 mL | 72.6111 mL |
| 5 mM | 0.5809 mL | 2.9044 mL | 5.8089 mL | 11.6178 mL | 14.5222 mL |
| 10 mM | 0.2904 mL | 1.4522 mL | 2.9044 mL | 5.8089 mL | 7.2611 mL |
| 50 mM | 0.0581 mL | 0.2904 mL | 0.5809 mL | 1.1618 mL | 1.4522 mL |
| 100 mM | 0.029 mL | 0.1452 mL | 0.2904 mL | 0.5809 mL | 0.7261 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Desoxygambogenin
Catalog No.:BCN3068
CAS No.:173614-93-2
- 2,3-Didehydrosomnifericin
Catalog No.:BCN8005
CAS No.:173614-88-5
- Oxotremorine sesquifumarate
Catalog No.:BCC6814
CAS No.:17360-35-9
- 3,5-Dinitro-Tyr-OH
Catalog No.:BCC3331
CAS No.:17360-11-1
- Compound W
Catalog No.:BCC2341
CAS No.:173550-33-9
- Naphthoquine phosphate
Catalog No.:BCC1784
CAS No.:173531-58-3
- HMN-214
Catalog No.:BCC2517
CAS No.:173529-46-9
- Ficusin A
Catalog No.:BCN1115
CAS No.:173429-83-9
- Rotundanonic acid
Catalog No.:BCN7152
CAS No.:173357-19-2
- Afobazole
Catalog No.:BCC5386
CAS No.:173352-21-1
- Pelargonidin-3,5-O-diglucoside chloride
Catalog No.:BCN1527
CAS No.:17334-58-6
- Aliskiren Hemifumarate
Catalog No.:BCC5018
CAS No.:173334-58-2
- TBB
Catalog No.:BCC1988
CAS No.:17374-26-4
- BGC 20-761
Catalog No.:BCC7650
CAS No.:17375-63-2
- Gambogin
Catalog No.:BCN3069
CAS No.:173792-67-1
- H-Gly-OBzl.HCl
Catalog No.:BCC2949
CAS No.:1738-68-7
- H-Ser-OBzl.HCl
Catalog No.:BCC3030
CAS No.:1738-72-3
- H-Gly-OBzl.TosOH
Catalog No.:BCC2948
CAS No.:1738-76-7
- H-Leu-OBzl.TosOH
Catalog No.:BCC2970
CAS No.:1738-77-8
- Swertiamarin
Catalog No.:BCN1116
CAS No.:17388-39-5
- Y-39983 dihydrochloride
Catalog No.:BCC4186
CAS No.:173897-44-4
- FR 171113
Catalog No.:BCC7734
CAS No.:173904-50-2
- Isocarapanaubine
Catalog No.:BCN1117
CAS No.:17391-09-2
- Corynoxine B
Catalog No.:BCN8454
CAS No.:17391-18-3
Theogallin and L-theanine as active ingredients in decaffeinated green tea extract: I. electrophysiological characterization in the rat hippocampus in-vitro.[Pubmed:17725856]
J Pharm Pharmacol. 2007 Aug;59(8):1131-6.
The in-vitro hippocampus slice preparation was used to mimic a physiological situation where nervous tissue is exposed directly to the water soluble extract of green tea and some of its constituents. This investigation provides evidence that L-theanine- and theogallin-enriched decaffeinated green tea extract is able to change the physiological pattern of electrical hippocampus activity in a concentration dependent manner (EC50 3 mg L(-1)). Of the seven fractions or single components tested (fraction containing all amino acids without L-theanine, fractions containing all amino acids plus L-theanine, glutamic acid, theogallin, its metabolites quinic acid and gallic acid, and L-theanine alone), glutamic acid produced the strongest changes in terms of increased population spike amplitude after single stimuli and increased long-term potentiation, commonly taken as representative for enhancement of spatial and time dependent memory. The presence of theogallin alone shifted the activity in the same direction. Similar results as with theogallin were obtained in the presence of quinic acid. No effect was seen with gallic acid. Opposite changes (decrease of population spike amplitude and attenuated long-term potentiation) were observed in the presence of L-theanine alone. No effects were detected during the addition of the amino acid mixture unless L-theanine was added, leading to a decrease of the responses as observed for the action of L-theanine alone. The results provide evidence for the involvement of several active principles in the action of enriched green tea extract on electrical brain activity. The overall enhancement of hippocampal pyramidal cell responses as observed for the crude extract seems to be due to the combined action of glutamic acid and theogallin (or its presumable metabolite quinic acid), whereas L-theanine seems to have an opposite effect. However, this action was not strong enough to antagonize the effects of glutamic acid and theogallin. The results are in line with the observation that the tested green tea extract improves cognition at concomitant mental relaxation in man.
